Abstract
The rapid development of the pharmaceutical market is determined by its life priority, since from the very beginning of life, humanity requires the regular consumption of drugs and medical devices to maintain the level of health necessary for a full life. The pharmaceutical market is an important sector of the economy of any country as a criterion for economic and social development, the well-being of the population. The developed pharmaceutical industry of a country is a highly innovative indicator of its economy. Pharmaceuticals have become the most profitable industry for investors today. The pharmaceutical market in Kazakhstan is the largest and most structured in Central Asia. However, it is weaker compared to the CEE (Central and Eastern Europe) market in terms of the business environment and its volume. This article summarizes how some of the current pharmaceutical companies were formed and how they reached maturity. There are a number of challenges facing the drug discovery industry as a whole, whether the company is a large pharmaceutical company or a biotech company that is just getting started. The purpose of this study is to analyze the current state of the pharmaceutical market in Kazakhstan, including a brief excursion into the history of its development and immediate prospects, based on the data of the following international and domestic organizations. The article examines the pharmaceutical market of Kazakhstan, including the production of basic pharmaceutical products, and also conducts a SWOT analysis of the pharmaceutical industry in Kazakhstan, describes the concept of a medicine market, analyzes the economic laws used in the market and its features.